REC Interventional Cardiology最新文献

Safety and efficacy profile of excimer laser coronary angioplasty for thrombus removal in STEMI. 准分子激光冠状动脉成形术治疗STEMI血栓清除的安全性和有效性分析。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-11-10 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000537

Mohsen Mohandes, Alberto Pernigotti, Mauricio Torres, Cristina Moreno, Humberto Coimbra, Roberto Bejarano, Jordi Guarinos, Francisco Fernández, José Luis Ferreiro

{"title":"Safety and efficacy profile of excimer laser coronary angioplasty for thrombus removal in STEMI.","authors":"Mohsen Mohandes, Alberto Pernigotti, Mauricio Torres, Cristina Moreno, Humberto Coimbra, Roberto Bejarano, Jordi Guarinos, Francisco Fernández, José Luis Ferreiro","doi":"10.24875/RECICE.M25000537","DOIUrl":"https://doi.org/10.24875/RECICE.M25000537","url":null,"abstract":"Introduction and objectives: Thrombus removal in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) can be challenging in the presence of a large thrombus burden. Excimer laser coronary angioplasty (ELCA) is an adjuvant device capable of vaporizing thrombus. This study aimed to evaluate the safety and efficacy profile of ELCA in PCI.Methods: Patients with STEMI undergoing PCI with concomitant use of ELCA for thrombus removal were retrospectively identified at our center. Data were collected on the device efficacy and its contribution to overall procedural success. Additionally, ELCA-related complications and major adverse cardiovascular events were recorded at a 2-year follow-up.Results: ELCA was used in 130 STEMI patients, 124 (95.4%) of whom had a large thrombus burden. TIMI grade flow improved significantly after ELCA: before laser application, TIMI grade-0 flow was reported in 79 (60.8%) cases and TIMI grade-1 flow in 32 (24.6%) cases. After ELCA, TIMI grade-2 and 3 flows were achieved in 45 (34.6%) and 66 (50.8%) cases, respectively (P < .001). Technical and procedural success were achieved in 128 (98.5%) and 124 (95.4%) cases, respectively. The complications included 1 death at the cath lab (0.8%), 1 coronary perforation (0.8%), and 3 distal embolizations (2.3%). At the 2-years follow-up, major adverse cardiovascular events occurred in 18.3% of the population.Conclusions: In the context of STEMI, ELCA seems to be an effective device for thrombus dissolution, with adequate technical and procedural success rates. In the present cohort, ELCA use was associated with a low complication rate and favorable long-term outcomes.","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 1","pages":"26-31"},"PeriodicalIF":1.1,"publicationDate":"2025-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The role of angiography-derived physiological assessment techniques in the post-FAVOR III Europe era? 血管造影衍生的生理评估技术在后favor III欧洲时代的作用？

IF 1.1

REC Interventional Cardiology Pub Date : 2025-11-10 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000546

Adrián Jerónimo, Enrique Gutiérrez-Ibañes

引用次数: 0

An interview with Camino Bañuelos. 采访卡米诺Bañuelos。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-11-03 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000550

Pilar Jiménez Quevedo, Ana Belén Cid Álvarez

引用次数: 0

Embolization of left atrial appendage occluders: review of the current evidence. 左心耳闭塞器栓塞术：当前证据的回顾。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-10-30 eCollection Date: 2026-01-01 DOI: 10.24875/RECIC.M25000553

Miguel Á Martín-Arena, Guillermo Galeote-García, Alejandro Lara-García, Alfonso Jurado-Román, Santiago Jiménez-Valero, Ariana Gonzálvez-García, Daniel Tébar-Márquez, Borja Rivero-Santana, Jon Zubiaur, Mattia Basile, Silvia Valbuena-López, Lucía Fernández-Gassó, Regina Dalmau González-Gallarza, Raúl Moreno

引用次数: 0

Usability and accuracy of a cloud-based sizing software for left atrial appendage closure. 一种基于云的左心耳闭合尺寸软件的可用性和准确性。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-10-08 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000536

Akash Jain, Mario García-Gómez, Marcelo Rodríguez, Luc Verstraeten, Johan Vogelaar, Ignacio J Amat-Santos

引用次数: 0

REC: Interventional Cardiology is now indexed in PubMed Central, the ultimate indexing. REC：介入心脏病学现在被PubMed Central索引，这是最终的索引。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-10-07 eCollection Date: 2025-01-01 DOI: 10.24875/RECICE.M25000541

José M de la Torre-Hernández, Fernando Alfonso, Raúl Moreno, Soledad Ojeda, Armando Pérez de Prado, Rafael Romaguera

引用次数: 0

Clinical clustering of TAVI patients: multivariate profiling and outcome associations using two-step cluster analysis. TAVI患者的临床聚类：使用两步聚类分析的多变量分析和结果关联。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-09-30 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000538

António Rocha de Almeida, Rafael Viana, Renato Fernandes, Ângela Bento, Lino Patrício

引用次数: 0

Sirolimus-coated balloon in young versus old patients with coronary artery disease: a sub-analysis of the EASTBOURNE study. 西罗莫司包被球囊在年轻冠状动脉疾病患者和老年冠状动脉疾病患者中的应用：EASTBOURNE研究的亚分析

IF 1.1

REC Interventional Cardiology Pub Date : 2025-09-29 eCollection Date: 2025-01-01 DOI: 10.24875/RECICE.M25000532

Filippo Luca Gurgoglione, Alfonso Ielasi, Irene Bossi, Roberto Latini, Bernardo Cortese

引用次数: 0

Expanding the role of drug-coated balloons in native large coronary artery disease. 扩大药物包被球囊在原生大冠状动脉疾病中的作用。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-09-29 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000542

Antonio Colombo, Pier Pasquale Leone

引用次数: 0

Drug-coated balloons vs drug-eluting stents for the treatment of large native coronary artery disease. Meta-analysis of randomized controlled trials. 药物包被球囊与药物洗脱支架治疗大面积原生冠状动脉疾病的比较随机对照试验的meta分析。

IF 1.1

REC Interventional Cardiology Pub Date : 2025-09-29 eCollection Date: 2026-01-01 DOI: 10.24875/RECICE.M25000527

José Antonio Sorolla Romero, Laura Novelli, Jorge Llau García, Sara Huélamo Montoro, Pablo Rubio, José Luis Díez Gil, Luis Martínez-Dolz, Ignacio J Amat Santos, Bernardo Cortese, Fernando Alfonso, Hector M Garcia-Garcia, Jorge Sanz-Sánchez

{"title":"Drug-coated balloons vs drug-eluting stents for the treatment of large native coronary artery disease. Meta-analysis of randomized controlled trials.","authors":"José Antonio Sorolla Romero, Laura Novelli, Jorge Llau García, Sara Huélamo Montoro, Pablo Rubio, José Luis Díez Gil, Luis Martínez-Dolz, Ignacio J Amat Santos, Bernardo Cortese, Fernando Alfonso, Hector M Garcia-Garcia, Jorge Sanz-Sánchez","doi":"10.24875/RECICE.M25000527","DOIUrl":"https://doi.org/10.24875/RECICE.M25000527","url":null,"abstract":"Introduction and objectives: To compare the effects of drug-coated balloon (DCB) vs drug-eluting stent (DES) in patients presenting with de novo large vessel coronary artery disease (CAD).Methods: We conducted a systematic research of randomized controlled trials comparing DCB vs DES in patients with de novo large vessel CAD. Data were pooled by meta-analysis using a random-effects model. The prespecified primary endpoint was target lesion revascularization (TLR).Results: A total of 7 trials enrolling 2961 patients were included. The use of DCB vs DES was associated with a similar risk of TLR (OR, 1.21; 95%CI, 0.44-3.30; I2 = 48%), all-cause mortality (OR, 1.56; 95%CI, 0.942.57; I2 = 0%), cardiac death (OR, 1.65; 95%CI, 0.90-3.05; I2 = 0%), myocardial infarction (OR, 0.97; 95%CI, 0.58-1.61; I2 = 0%), major adverse cardiovascular adverse (OR, 1.19; 95%CI, 0.74-1.90; I2 = 13.5%) and late lumen loss (standardized mean difference [SMD], -0.35; 95%CI, -0.74 to 0.04; I2 = 81.4%). However, the DCB was associated with a higher risk of target vessel revascularization (OR, 2.47; 95%CI, 1.52-4.03; I2 = 0%) and smaller minimal lumen diameter during late follow-up (SMD, -0.36; 95%CI, -0.56 to -0.15; I2 = 34.5%). Nevertheless, prediction intervals included the value of no difference for both outcomes.Conclusions: In patients with de novo large vessel CAD the use of DCB vs DES is associated with a similar risk of TLR. However, the DES achieves better late angiographic results.","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 1","pages":"8-16"},"PeriodicalIF":1.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0